Powerful collaborations, cutting-edge science, and curious minds coming together for a glimpse of the future.

Stay tuned as we look at the latest updates on some of the most promising technology projects.

Hello and welcome. I'm Peter Ballant from Technicon, and today we take a closer look at the

IPC project. IPC stands for individualized pediatric cure. In this European Union-funded

project, doctors, clinicians, oncologists, biomedical engineers, and computer

scientists converge for a noble cause, helping to save the lives of children with cancer.

This is a huge effort involving partners from across the globe.

Today we were lucky enough to speak remotely with Dr. Pavel Sumazen from Baylor College of Medicine.

Baylor is the largest pediatric cancer center in the USA. Dr. Sumazen is a partner among many

in IPC. Let me say welcome and we can start off by jumping into the first and most important

question. What is IPC trying to accomplish?

So the intent behind the IPC is to get us to the point, get us at least closer to the goal,

that we are able to model diseases and patients, and to use these models to improve the quality of treatment and to reduce

toxicity. What makes us special is that we are trying to put computational sort of know-how

together with a large collection of molecular data from multiple types of pediatric

cancers. So that essentially, based on some tests that a physician would do or a hospital

would do, we would be able to predict which drugs or which treatments are more likely to

succeed and more likely to have less long-term effects.

And pediatric cancer, one of the big problems is that often when treatment succeeds, we measure

success based on the survival of the patient.

Cancer has a high mortality rate.

So our goal is to keep the patients alive.

...